CHIP, mCAs Are Each Associated With Increased Risk Of Developing Breast Cancer And Dying From Colorectal Cancer, Study Finds

Cancer Therapy Advisor (7/31, Lawrence) reports, “Clonal hematopoiesis of indeterminate potential (CHIP) and mosaic chromosomal alterations (mCAs) are each associated with an increased risk of developing breast cancer and dying from colorectal cancer, according to research.” Investigators came to this conclusion after analyzing “whole-genome sequencing data from 11,029 women in the Trans-Omics for Precision Medicine cohort of the Women’s Health Initiative study.” The findings were published in Cancer.